Fundraising Fox
DiscGenics, Inc.
Salt Lake City, US · Founded 2008 · 2 known investors
Find your way into DiscGenics, Inc.
Sign up to see every warm intro you have to DiscGenics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DiscGenics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
DiscGenics develops an allogeneic, injectable disc progenitor cell therapy (IDCT/rebonuputemcel) for painful lumbar degenerative disc disease, currently advancing toward a Phase III clinical program. The company works in regenerative spine medicine and cell therapy, and collaborates on tissue-engineered intervertebral disc research.
Founders & leadership
DiscGenics, Inc. was founded in 2008 by Dr. Valery Kukekov and Kevin T. Foley, M.D..
DV
Dr. Valery KukekovCo-founder
KT
Kevin T. Foley, M.D.Co-founder; Chief Medical Officer, Director
FF
Flagg FlanaganChief Executive Officer & Chairman of the BoardFlagg Flanagan brings over three decades of experience in medical devices through founding and leading multiple companies. He previously built and sold Flanagan Instruments, a neurosurgical device distributor, to Itochu International, and has served on boards including TrueVision Systems and Image Stream Medical (acquired by Olympus in 2017).
BW
Bob WynalekCOO & Board MemberBob Wynalek is COO and Board Member of DiscGenics, a regenerative medicine company developing cell therapies for degenerative disc disease. He brings 35 years of experience in biopharmaceuticals, orthobiologics, and medical devices across regenerative therapies, spine, and orthopedic markets, with leadership roles spanning early-stage, clinical-stage, and commercial organizations.
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BSep 2017
Mitsubishi UFJ Capital Co. Ltd (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does DiscGenics, Inc. do?
- DiscGenics develops an allogeneic, injectable disc progenitor cell therapy (IDCT/rebonuputemcel) for painful lumbar degenerative disc disease, currently advancing toward a Phase III clinical program. The company works in regenerative spine medicine and cell therapy, and collaborates on tissue-engineered intervertebral disc research.
- Who founded DiscGenics, Inc.?
- DiscGenics, Inc. was founded by Dr. Valery Kukekov, Kevin T. Foley, M.D. in 2008.
- Who are DiscGenics, Inc.'s investors?
- DiscGenics, Inc.'s investors include Medical Incubator Japan K.K., Mitsubishi UFJ Capital.
- Where is DiscGenics, Inc. headquartered?
- DiscGenics, Inc. is headquartered in Salt Lake City, US.